Unlock instant, AI-driven research and patent intelligence for your innovation.

Synthesis method for co-production of N-hydroxyethyl piperazine and N-ethyl piperazine

A technology of hydroxyethylpiperazine and ethylpiperazine, applied in the field of synthesis of N-hydroxyethylpiperazine co-production of N-ethylpiperazine, can solve the problem of high raw material prices affecting the production of N-ethylpiperazine Efficiency, danger and other issues, to achieve the effect of low raw material price, good industrialization prospect and high conversion rate

Active Publication Date: 2021-03-09
SHANDONG GUOBANG PHARMA +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the route for industrially synthesizing N-hydroxyethylpiperazine is mainly from the addition of piperazine and ethylene oxide, but ethylene oxide is highly active and easily produces N,N-dihydroxyethylpiperazine impurities , and synthesized with ethylene oxide as raw material, the raw material price is relatively high, and it is a flammable, explosive and toxic gas, which is dangerous in production
[0004] At present, the main raw materials for producing N-ethylpiperazine are piperazine and ethanol, but the activity of ethanol is relatively high. If the one-way conversion rate of piperazine is higher than 40%, it is easy to produce impurity N,N-diethylpiperazine impurity , affecting the production efficiency of N-ethylpiperazine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method for co-production of N-hydroxyethyl piperazine and N-ethyl piperazine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Take 172g (2mol) of anhydrous piperazine into a four-neck flask with mechanical stirring, add 344g of anhydrous methanol to dissolve, add 5.4g (0.1mol) of anhydrous sodium methoxide, stir at 600-700rpm, and slowly drop in Add 172.8g (1.92mol) methyl glycolate, control the dropping time for 6 hours, and control the temperature during the dropping process to 30°C; after the dropping is completed, stir at 300-500rpm for 2 hours, turn on the vacuum system, recover the solvent, and take samples in the middle to detect until The solvent is recovered cleanly, and the material is transferred into an autoclave;

[0031] Add 344g of toluene, put in 17.2g of Raney nickel as a catalyst, tighten the lid of the kettle, replace the air three times after the nitrogen leak test, and replace it with hydrogen twice;

[0032] Turn on the stirring at 400-600rpm, raise the temperature at the same time, raise the temperature to 200°C, fill in hydrogen to keep the pressure at 5±0.5MPa, observe...

Embodiment 2

[0035] This implementation method is different from Example 1 in that the ammonium solution catalyst is 10.6g (0.1mol) of sodium carbonate, and the other steps are the same to obtain N-ethylpiperazine 59.51g with a purity of 99.5%; N-hydroxyethylpiperazine 158.34 g, purity 99.7%, total molar yield 87.0%.

Embodiment 3

[0037] The difference between this implementation method and Example 1 is that the ammonium solution catalyst is 10.0 g (0.1 mol) of potassium bicarbonate, and the other steps are the same to obtain 57.68 g of N-ethylpiperazine with a purity of 99.6%; N-hydroxyethylpiperazine 152.36g, purity 99.6%, total molar yield 83.9%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for co-production of N-hydroxyethyl piperazine and N-ethyl piperazine. The method comprises the following steps: reacting methyl glycolate serving as a process intermediate for preparing ethylene glycol by a coal method with piperazine to generate an intermediate product carbonyl hydroxyethyl piperazine, then in the presence of a hydrogenation catalyst, carrying out hydrogenation reduction and dehydration under certain pressure and temperature conditions to obtain N-hydroxyethyl piperazine, and simultaneously co-producing part of N-hydroxyethyl piperazine. Themethod is simple and convenient, low in cost, high in total yield, good in selectivity, easy in product separation and environment-friendly.

Description

technical field [0001] The invention belongs to the technical field of organic chemical industry, and also belongs to the technical field of synthesis of veterinary drugs and pharmaceutical raw materials, in particular to a synthesis method for co-production of N-hydroxyethylpiperazine and N-ethylpiperazine. Background technique [0002] N-Hydroxyethylpiperazine is an important intermediate in the production of triethylenediamine, surfactants, medicines, and pesticides, and can be used to synthesize psychotropic drugs such as fluphenazine; it is also an excellent desulfurization and decarburization agent, which can be widely used Used in the environmental protection industry; it can also be used as an electronic chemical in the electronics industry. As an intermediate, N-ethylpiperazine is mainly used in the production of veterinary drugs ethyl ciprofloxacin and anthranofloxacin, and can also be used as a synthetic raw material for dyes and plant protection agents. [0003]...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D295/023C07D295/03C07D295/088
CPCC07D295/023C07D295/03C07D295/088
Inventor 邱正洲何泽骁钟志军张小垒刘聪
Owner SHANDONG GUOBANG PHARMA